Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q36142604)
Watch
English
Targeting the HGF/Met signalling pathway in cancer.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
3412517
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20303741%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
review article
1 reference
stated in
Europe PubMed Central
title
Targeting the HGF/Met signalling pathway in cancer
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
3412517
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20303741%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
author
Franco Cecchi
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
3412517
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20303741%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
Daniel C Rabe
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
3412517
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20303741%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
Donald P. Bottaro
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
3412517
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20303741%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
author name string
Fabiola Cecchi
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
3412517
retrieved
12 August 2017
language of work or name
English
1 reference
based on heuristic
inferred from title
publication date
19 March 2010
1 reference
stated in
Europe PubMed Central
PMC publication ID
3412517
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20303741%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
published in
European Journal of Cancer
1 reference
stated in
Europe PubMed Central
PMC publication ID
3412517
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20303741%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
volume
46
1 reference
stated in
Europe PubMed Central
PMC publication ID
3412517
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20303741%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
issue
7
1 reference
stated in
Europe PubMed Central
PMC publication ID
3412517
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20303741%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
page(s)
1260-1270
1 reference
stated in
Europe PubMed Central
PMC publication ID
3412517
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20303741%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
cites work
The MET axis as a therapeutic target
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
E7050: a dual c-Met and VEGFR-2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft models
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Novel therapeutic inhibitors of the c-Met signaling pathway in cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Single-agent and combination therapeutic strategies to inhibit hepatocyte growth factor/MET signaling in cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
A novel multipurpose monoclonal antibody for evaluating human c-Met expression in preclinical and clinical settings
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonist
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
From Tpr-Met to Met, tumorigenesis and tubes.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Tyrosine kinase mutations in human cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Overexpression of NK2 inhibits liver regeneration after partial hepatectomy in mice
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Renal fibrosis: new insights into the pathogenesis and therapeutics
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Somatic mutations lead to an oncogenic deletion of met in lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
The Akt/PKB pathway: molecular target for cancer drug discovery
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
A protein canyon in the FGF-FGF receptor dimer selects from an à la carte menu of heparan sulfate motifs
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Mechanisms and significance of bifunctional NK4 in cancer treatment.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Cancer therapy: can the challenge be MET?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
A mouse model of activating Met mutations
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Hereditary papillary renal carcinoma type I
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
The interactions of hepatocyte growth factor/scatter factor and its NK1 and NK2 variants with glycosaminoglycans using a modified gel mobility shift assay. Elucidation of the minimal size of binding and activatory oligosaccharides
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Met provides essential signals for liver regeneration
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Therapeutic angiogenesis using hepatocyte growth factor (HGF).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Met, metastasis, motility and more
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
c-Met: structure, functions and potential for therapeutic inhibition
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
How to make tubes: signaling by the Met receptor tyrosine kinase
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
HGF/SF-met signaling in the control of branching morphogenesis and invasion
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Met receptor tyrosine kinase: enhanced signaling through adapter proteins
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Frequency of TPR-MET rearrangement in patients with gastric carcinoma and in first-degree relatives
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Differential effects of hepatocyte growth factor isoforms on epithelial and endothelial tubulogenesis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Scatter factor/hepatocyte growth factor is essential for liver development
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Identification of a Competitive HGF Antagonist Encoded by an Alternative Transcript
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 October 2017
Enzymatic characterization of c-Met receptor tyrosine kinase oncogenic mutants and kinetic studies with aminopyridine and triazolopyrazine inhibitors.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 July 2018
Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: modeling studies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 July 2018
Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 July 2018
Novel mutations of the MET proto-oncogene in papillary renal carcinomas.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 July 2018
Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 July 2018
The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 July 2018
Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
2 July 2018
Rilotumumab, a mAb against human hepatocyte growth factor for the treatment of cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
23 September 2018
C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
23 September 2018
The Sema domain of Met is necessary for receptor dimerization and activation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
23 September 2018
Different point mutations in the met oncogene elicit distinct biological properties.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
23 September 2018
Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
23 September 2018
Silencing the MET oncogene leads to regression of experimental tumors and metastases
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412517
retrieved
5 December 2018
Processing of hepatocyte growth factor to the heterodimeric form is required for biological activity
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/20303741
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Overexpression of hepatocyte growth factor/scatter factor promotes vascularization and granulation tissue formation in vivo
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/20303741
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Constitutive c-Met signaling through a nonautocrine mechanism promotes metastasis in a transgenic transplantation model
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/20303741
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1016/J.EJCA.2010.02.028
1 reference
stated in
Europe PubMed Central
PMC publication ID
3412517
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20303741%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
PMC publication ID
3412517
1 reference
stated in
Europe PubMed Central
PMC publication ID
3412517
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20303741%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
PubMed publication ID
20303741
1 reference
stated in
Europe PubMed Central
PMC publication ID
3412517
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20303741%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
ResearchGate publication ID
42370702
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit